We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter
Est. Return
+9.96%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$51.2B
AUM Growth
+$4.14B
(+8.8%)
Cap. Flow
+$2.35B
Cap. Flow
% of AUM
4.58%
Top 10 Holdings %
Top 10 Hldgs %
19.89%
Holding
3,234
New
648
Increased
710
Reduced
838
Closed
835
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.99B |
| 2 |
Microsoft
MSFT
|
+$522M |
| 3 |
Advanced Micro Devices
AMD
|
+$511M |
| 4 |
Amazon
AMZN
|
+$318M |
| 5 |
Apple
AAPL
|
+$317M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$402M |
| 2 |
McDonald's
MCD
|
+$375M |
| 3 |
Visa
V
|
+$366M |
| 4 |
Meta Platforms (Facebook)
META
|
+$319M |
| 5 |
Adobe
ADBE
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.66% |
| 2 | Healthcare | 17.11% |
| 3 | Miscellaneous | 15.83% |
| 4 | Consumer Discretionary | 13.3% |
| 5 | Financials | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
PUT
Booking.com
BKNG
$135B
| $1.62M | ﹤0.01% |
15,000
+7,500
| +100% | +$792K |
|
1477
Ubiquiti
UI
$35.1B
| $1.62M | ﹤0.01% |
+9,217
| New | +$1.86M |
|
1478
PUT
VanEck Junior Gold Miners ETF
GDXJ
$9.47B
| $1.62M | ﹤0.01% |
45,400
-38,100
| -46% | -$1.48M |
|
|
AUROW
1479
CALL
Aurora Innovation Warrant
AUROW
$96.9M
| $1.62M | ﹤0.01% |
550,000
| – | – |
|
1480
SEI Investments
SEIC
$13B
| $1.62M | ﹤0.01% |
+27,100
| New | +$1.58M |
|
1481
Suzano
SUZ
$11.4B
| $1.61M | ﹤0.01% |
174,946
-255,088
| -59% | -$2.23M |
|
|
1482
CALL
VanEck Junior Gold Miners ETF
GDXJ
$9.47B
| $1.61M | ﹤0.01% |
45,200
+17,100
| +61% | +$665K |
|
1483
Blue Owl Capital
OWL
$7.67B
| $1.61M | ﹤0.01% |
+138,100
| New | +$1.49M |
|
1484
Banco Santander Chile
BSAC
$16.7B
| $1.61M | ﹤0.01% |
85,270
+162
| +0.2% | +$3.02K |
|
1485
OptimizeRx
OPRX
$143M
| $1.6M | ﹤0.01% |
112,132
+24,803
| +28% | +$353K |
|
1486
Park Aerospace
PKE
$701M
| $1.6M | ﹤0.01% |
115,933
+31,241
| +37% | +$413K |
|
|
CXAC.WS
1487
CALL
DELISTED
C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
CXAC.WS
| $1.6M | ﹤0.01% |
149,998
| – | – |
|
1488
Vale
VALE
$66.2B
| $1.59M | ﹤0.01% |
118,837
-3,279,850
| -97% | -$46.4M |
|
1489
International Flavors & Fragrances
IFF
$21.8B
| $1.59M | ﹤0.01% |
+20,013
| New | +$1.72M |
|
1490
GDS Holdings
GDS
$6.41B
| $1.59M | ﹤0.01% |
144,268
-308,611
| -68% | -$4.1M |
|
1491
QuidelOrtho
QDEL
$918M
| $1.58M | ﹤0.01% |
+19,123
| New | +$1.67M |
|
1492
Stellus Capital Investment Corp
SCM
$239M
| $1.58M | ﹤0.01% |
+112,475
| New | +$1.6M |
|
1493
CI&T Inc
CINT
$412M
| $1.57M | ﹤0.01% |
+250,838
| New | +$1.21M |
|
1494
Synaptics
SYNA
$3.7B
| $1.57M | ﹤0.01% |
+18,400
| New | +$1.6M |
|
1495
The Joint Corp
JYNT
$116M
| $1.57M | ﹤0.01% |
116,105
-60,393
| -34% | -$887K |
|
|
1496
PUT
Visa
V
$688B
| $1.57M | ﹤0.01% |
6,600
-2,500
| -27% | -$572K |
|
1497
Arch Capital
ACGL
$32.7B
| $1.55M | ﹤0.01% |
20,700
+16,700
| +418% | +$1.21M |
|
1498
CALL
Tevogen Inc Warrant
TVGNW
$949K
| $1.55M | ﹤0.01% |
144,415
-5,584
| -4% | -$302 |
|
|
MTLS
1499
Materialise
MTLS
$437M
| $1.54M | ﹤0.01% |
178,399
+151,107
| +554% | +$1.31M |
|
1500
Aldeyra Therapeutics
ALDX
$92.9M
| $1.54M | ﹤0.01% |
183,337
+106,232
| +138% | +$1.05M |
|
Similar funds
Marshall Wace's Q2 2023 Portfolio in Review
As of Q2 2023, Marshall Wace held 3,234 positions worth $51.2B, up 8.8% from $47.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace deployed $2.35B of net new capital in Q2 2023, opening 648 new positions and adding to 710 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Healthcare and Miscellaneous.
On the sell side, the largest reduction was Gilead Sciences, an estimated $402M trimmed.
- Marshall Wace's largest Q2 2023 buy was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B.
- Marshall Wace added most to Microsoft in Q2 2023, an estimated $522M increase.
- Marshall Wace's biggest Q2 2023 reduction was Gilead Sciences, cutting an estimated $402M.
- Marshall Wace fully exited Cloudflare in Q2 2023, selling an estimated $136M.
- Marshall Wace's ten largest holdings make up 20% of its $51.2B portfolio in Q2 2023.
- Marshall Wace opened 648 new positions and closed 835 in Q2 2023.
- Marshall Wace's portfolio value rose 8.8% quarter-over-quarter to $51.2B.
Based on Marshall Wace's 13F filing for Q2 2023, filed 14 Aug 2023.